Chan Henry Lee Sells $236K of BeOne Medicines Ltd (ONC) — SEC Form 4, Jun 10, 2026
Open-Market Net Sale · SEC Form 4
−$235,539
Equity position changed by -0.3%
Equity Position
307K sh
307,918 → 307,047
Equity Change
-0.3%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Chan Henry Lee CIK 0001980648 |
GC
|
Chan Henry Lee at BeOne Medicines Ltd
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$4,632,539
More from this insider at BeOne Medicines Ltd
| 2026-10-02 | Sell | -$418,125 | View |
| 2026-08-14 | Sell | -$959,760 | View |
| 2026-08-03 | Sell | -$337,932 | View |
| 2026-07-24 | Sell | -$542,425 | View |
| 2026-07-10 | Sell | -$200,833 | View |
Non-Derivative Securities Transactions
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Ordinary Shares | 307,047 | Direct |
Footnotes (4)
- F1
- Each American Depositary Share represents 13 Ordinary Shares. Show more
- F2
- The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. Show more
- F3
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.90 to $270.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
- F4
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.00 to $271.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Show more
Related filings at BeOne Medicines Ltd
Institutional Holders
13F holders · Jun 30, 2026
284
institutional managers reporting a position
Largest by reported value
- Baker Bros. Advisors Lp $2.51B
- Primecap Management Co/Ca/ $1.43B
- Capital International Investors $1.2B
5%+ Holders · 13D/G
2 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at BeOne Medicines Ltd
-
Xiaodong Wang -$11.3M
-
Xiaodong Wang -$10.9M
-
Xiaodong Wang -$11.3M
-
Xiaodong Wang -$13.4M
GET /v1/forms/4/0001980648-26-000013
API docs
View Original SEC Filing